Vraylar
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
61874-130 -
Package NDC
61874-130-07 -
Package NDC
61874-130-20 -
Package NDC
61874-130-30 -
Application number
NDA204370 -
SPL ID
ef3db4f6-9b04-4ffe-b72e-7ab3ceccb224 -
SPL set ID
4b5f7c65-aa2d-452a-b3db-bc85c06ff12f -
UNII
F6RJL8B278 -
RxCUI
1667660 -
RxCUI
1667666 -
RxCUI
1667668 -
RxCUI
1667670 -
RxCUI
1667672 -
RxCUI
1667674 -
RxCUI
1667676 -
RxCUI
1667678 -
RxCUI
1741746 -
RxCUI
1741747 -
RxCUI
2729792 -
RxCUI
2729794 -
RxCUI
2729796 -
RxCUI
2729798
What the source publishes
- Labeler
- Allergan, Inc.
- Active ingredients
- cariprazine
- Form
- CAPSULE, GELATIN COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Vraylar",
"splId": "ef3db4f6-9b04-4ffe-b72e-7ab3ceccb224",
"labels": [
{
"setId": "4b5f7c65-aa2d-452a-b3db-bc85c06ff12f",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4b5f7c65-aa2d-452a-b3db-bc85c06ff12f"
}
],
"routes": [
"ORAL"
],
"labeler": "Allergan, Inc.",
"finished": true,
"packaging": [
{
"sample": true,
"description": "7 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-130-07)",
"package_ndc": "61874-130-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20160301"
},
{
"sample": false,
"description": "2 BLISTER PACK in 1 CARTON (61874-130-20) / 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-130-11)",
"package_ndc": "61874-130-20",
"identifierStatus": "well-formed",
"marketing_start_date": "20160301"
},
{
"sample": false,
"description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-130-30)",
"package_ndc": "61874-130-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20160301"
}
],
"productId": "61874-130_ef3db4f6-9b04-4ffe-b72e-7ab3ceccb224",
"useDomain": "unknown",
"dosageForm": "CAPSULE, GELATIN COATED",
"productNdc": "61874-130",
"deaSchedule": null,
"genericName": "cariprazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARIPRAZINE",
"strength": "3 mg/1"
}
],
"applicationNumber": "NDA204370",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150917",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175430"
],
"upc": [
"0361874250305"
],
"unii": [
"F6RJL8B278"
],
"rxcui": [
"1667660",
"1667666",
"1667668",
"1667670",
"1667672",
"1667674",
"1667676",
"1667678",
"1741746",
"1741747",
"2729792",
"2729794",
"2729796",
"2729798"
],
"spl_set_id": [
"4b5f7c65-aa2d-452a-b3db-bc85c06ff12f"
],
"pharm_class_epc": [
"Atypical Antipsychotic [EPC]"
],
"manufacturer_name": [
"Allergan, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:61874-130_ef3db4f6-9b04-4ffe-b72e-7ab3ceccb224"